Anders Carlsson

Anders Carlsson has a diverse work experience in various scientific and research roles. Anders is the Founder and Chief Scientific Officer at Bionamic AB since March 2023. Prior to that, they served as the CEO of Bionamic AB from August 2019 to March 2023. Anders founded Sciscitor AB in January 2017 and continues to be associated with it.

Anders worked as a Research Scientist at the University of Southern California from August 2015 to December 2016. Anders also served as a Postdoctoral Scholar Visiting Fellow at the same university from December 2014 to July 2015.

Before joining USC, Anders worked as a Postdoctoral fellow at The Scripps Research Institute from February 2012 to December 2014. Anders'sresearch focused on using circulating tumor cells (CTCs) for cancer diagnostics, prognostics, and treatment efficiency monitoring.

Anders started their career at Lund University, where they worked as a Research Associate from October 2010 to February 2012. Anders also served as a PhD student at Lund University from May 2005 to September 2010. Anders'sdoctoral thesis involved the application of a recombinant antibody microarray platform for biomarker discovery in cancer and autoimmune diseases.

Overall, Anders Carlsson has a strong background in scientific research, specifically in the fields of cancer diagnostics, biomarker discovery, and circulating tumor cells.

Anders Carlsson's education history includes their completion of a Doctor of Philosophy (Ph.D.) degree in Immunotechnology from Lund University. Anders pursued this degree from 2006 to 2010. Prior to this, they also had an educational experience at Scripps Research, but the details regarding the duration and specific area of study are not provided.